Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
暂无分享，去创建一个
M. Bøgsted | K. Dybkær | U. Mellqvist | P. Sonneveld | H. Johnsen | R. Brøndum | M. Severinsen | A. Waage | N. Abildgaard | E. Haukås | M. Hansson | A. Schmitz | V. Velden | L. Ahlberg | B. Lauri | N. F. Andersen | P. Gimsing | J. Bødker | F. Schjesvold | H. Gregersen | U. Frølund | B. Holt | B. Andreasson | N. Gulbrandsen | A. Roug | C. Helleberg | D. H. Bruinink | Alexander Schmitz